Agamree

Indicated For

Duchenne muscular dystrophy (DMD)

About This Medication

# Catalyst Pathways Guide: Getting Agamree at Low Cost ## What is Agamree? Agamree (vamorolone) is a prescription medication used to treat Duchenne muscular dystrophy (DMD). It's manufactured by Catalyst Pharmaceuticals. This guide explains how to access Agamree through the Catalyst Pathways prescription assistance program if you're having trouble affording it. ## Who Can Apply? You may qualify for Catalyst Pathways if: - You have a valid prescription for Agamree from your doctor - Your annual household income falls within program limits (limits vary based on family size and state) - You are a U.S. resident - You are uninsured, underinsured, or your insurance doesn't cover Agamree Income limits are flexible and assessed on a case-by-case basis. Contact the program directly at (833) 422-8259 to discuss your specific situation. ## Insurance Coverage Help Catalyst Pathways works with your insurance company to verify coverage and explore all payment options. If your insurance is delayed in processing your claim, the program provides free medication through a bridge program so you don't have gaps in treatment. This means you can keep taking your medication while insurance matters are being sorted out. ## What You Need to Apply Gather these documents before applying: 1. **Insurance card** (front and back images or copies) 2. **Prescription** from your doctor for Agamree 3. **Signed forms** from you or your caregiver (the program will provide these) You do NOT need to reapply each year—your enrollment continues without reauthorization. ## How to Apply: 4 Simple Steps **Step 1: Contact the Program** Call (833) 422-8259 or visit https://www.yourcatalystpathways.com to start your application. A support specialist will answer your questions and help you decide which application method works best. **Step 2: Choose Your Application Method** You can apply by: - Phone with a program specialist - Online through the website - Mail (paper forms) **Step 3: Submit Required Documents** Provide your insurance card, prescription, and signed consent forms. You can submit these digitally, by phone, or by mail, depending on your chosen method. **Step 4: Wait for Approval** The program will review your application and contact you with approval status, usually within 1-2 weeks. Once approved, your medication will be shipped to you or your pharmacy. ## Savings Card Option If you have insurance that covers Agamree but face high copays or deductibles, ask about the Catalyst Pathways savings card. This card may reduce your out-of-pocket costs significantly at the pharmacy. ## What Happens After Approval? Once approved: - You'll receive Agamree at no cost or at a reduced cost based on your income - Your medication will be sent to you or your chosen pharmacy - You can continue receiving medication without annual reapplication - If you have insurance delays, the bridge program covers your medication at no charge - The program team remains available to answer questions and help with insurance issues ## If Your Application is Denied If denied, don't give up. You can: - Ask the program why your application wasn't approved - Provide additional financial documentation if your situation has changed - Reapply if your circumstances improve - Ask program staff about other payment options or assistance resources ## Timeline Expectations - **Application to approval:** 1-2 weeks - **Approval to first shipment:** 1-2 weeks - **Refills:** Automatic; no reauthorization needed ## Questions? **Phone:** (833) 422-8259 **Website:** https://www.yourcatalystpathways.com Program specialists are available to help explain eligibility, walk you through the application, answer questions about income limits, and troubleshoot any problems. ## Important Notes This program is designed specifically to help patients with DMD access Agamree affordably. There are no biosimilar alternatives to Agamree, making this assistance program especially important. The program works with Medicare patients and those with private insurance, Medicaid, or no insurance at all. Your privacy is protected. All information you provide is confidential and used only to process your assistance request.

Program information last verified: March 25, 2026